Mazzariello Gina

Chief Legal Officer

Mazzariello Gina has filed 8 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2025. 8 of those filings fall inside the rolling window. Most recent filing: Sep 14, 2026.

On the most recent filing, Mazzariello Gina is listed as Chief Legal Officer at Amylyx Pharmaceuticals, Inc. Inside the rolling window, Mazzariello Gina reported no open-market purchases and 7 open-market sales totaling $1.2M in AMLX. The largest disclosed transaction in the window is a sale of 9,536 AMLX shares on Sep 10, 2026, worth $310K.

Companies traded

Other insiders at AMLX

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1.2M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
AMLXSale$310KSep 14SEC ↗
AMLXSale$275KJul 13SEC ↗
AMLXSale$264KJul 13SEC ↗
AMLXSale$99KMar 4SEC ↗
AMLXSale$48KFeb 25SEC ↗
AMLXSale$51KFeb 4SEC ↗
AMLXSale$129KOct 2SEC ↗
Showing 1–7 of 7
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Mazzariello Gina made?

Mazzariello Gina has filed 8 SEC Form 4 filings (10 transaction rows) across 1 company since 2025.

Which companies does Mazzariello Gina trade?

Mazzariello Gina has filed SEC Form 4 disclosures for 1 company, including AMLX.

When was Mazzariello Gina's most recent SEC Form 4 filing?

Mazzariello Gina's most recent SEC Form 4 filing on Tracefour is dated Sep 14, 2026.

What is Mazzariello Gina's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Mazzariello Gina is listed as Chief Legal Officer.

What is Mazzariello Gina's total buy and sell value in the current window?

Inside the rolling retention window, Mazzariello Gina bought $0 and sold $1.2M based on SEC Form 4 filings.

What was Mazzariello Gina's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 9,536 AMLX shares on 2026-09-10, worth $310K, per SEC Form 4 filings.